HLRCC is associated with germline mutation of the Krebs cycle enzyme gene, fumarate hydratase (FH), and the resulting tumors demonstrate loss of the remaining wild-type allele [5–7]. The gene discussed is FH; the disease is hereditary leiomyomatosis and renal cell cancer.